A QUALITATIVE STUDY DISCOVERING THE COMMON MEDICATION-THERAPY PROBLEMS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN INDONESIA

Retno Wahyuningrum; Djoko Wahyono; Mustofa Mustofa; Yayi Suryo Prabandari

doi:10.22159/ajpcr.2017.v10i7.18217

Authors

Retno Wahyuningrum Doctoral Student, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia http://orcid.org/0000-0001-7713-2827
Djoko Wahyono Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Mustofa Mustofa Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Yayi Suryo Prabandari Department of Public Health, Faculty of Medicine, Center of Health Behavior and Promotion, Universitas Gadjah Mada, Yogyakarta, Indonesia.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i7.18217

Keywords:

Type 2 diabetes mellitus, Interviews, Medication-therapy problems, Patient perspective, Counseling, Non-pharmacological therapy

Abstract

Objective: Type 2 diabetes mellitus (T2DM) is a chronic and non-communicable diseases caused by insulin resistance. The management of the disease is not only carried out by administering pharmacological therapies, but also non-pharmacological. The aim of the overall study was to develop a model to improve the quality of counseling practice in pharmacies. The research question addressed in this substudy was to identify the medication therapy problems (MTPs) of T2DM.

Methods: A total of 42 participants were interviewed between November 2015 and May 2016 through semi-structured surveys. Face-to-face interviews were conducted with patients who visited the internal clinic in the three general hospitals at Yogyakarta. It emphasized on the patient's drug-related experiences, knowledge, perceptions, problems, and actions. The analysis was done thematically using the interpretative phenomenological analysis technique.

Results: The average age of participants was 57.7 years, and more than half were women (55.5%). The most common therapy-related problems are related to individual factors, in term of inappropriate lifestyle choices, which include smoking, having a body mass index value over 25, lack of exercise, lack of knowledge about the nature of their disease, some did not know about the influence of foods on blood glucose level, the effect of the medicines on the disease and/or complications. The interviewees had realized that psychological stress enhanced their blood glucose.

Conclusion: Pharmacists need to pay attention to the management of non-pharmacological when giving advice to patients with T2DM.

Â

Downloads

Download data is not yet available.

Author Biographies

Retno Wahyuningrum, Doctoral Student, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia

Department of Pharmacology and Clinical Pharmacy

Faculty of Pharmacy Universitas Gadjah Mada

Djoko Wahyono, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Pharmacology and Clinical Pharmacy Department Faculty of Pharmacy

Mustofa Mustofa, Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Pharmacology and Therapy Department

Faculty of Medicine

Yayi Suryo Prabandari, Department of Public Health, Faculty of Medicine, Center of Health Behavior and Promotion, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Center of Health Behavior and Promotion, Public Health Department, Faculty of Medicine

References

World Health Organization. Diabetes Country Profiles 2016. WHO; 2016. Available from: http://www.who.int/diabetes/country-profiles/en.

American Diabetes Association. Standards of medical care in diabetes-2016: Summary of revisions. Diabetes Care 2016;39 Suppl 1:S4-5. Available from: http://www.care. diabetesjournals.org/content/39/Supplement_1/S4.

Adusumilli P, Adepu R. Drug-related problems - An overview of various classification systems. Asian J Pharm Clin Res 2014;7(4):7-10.

HaugbÃ¸lle LS, SÃ¸rensen EW. Drug-related problems in patients with angina pectoris, Type 2 diabetes and asthma - Interviewing patients at home. Pharm World Sci 2006;28(4):239-47.

Zaman Huri H, Chai Ling L. Drug-related problems in Type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health 2013;13:1192.

Wahyuningrum R, Wahyono D, Mustofa, Prabandari YS. Medication-related problems in patients with Type 2 diabetes: A Qualitative interviews. In: Proceeding Book International Conference Cardiovascular Diseases (CVD-IA): Integrated Approach from Basic, Clinical Science, Public Healthh and Bioethics. Yogyakarta: Fakultas Kedokteran Universitas Islam Indonesia; 2016. p. 189-200. Available from: http://www.cvd-ia.uii.ac.id/wp-content/uploads/Proceeding- International-Conference-Book.pdf.

Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94(3):311-21.

Badan Litbangkes. Hasil Riset Kesehatan Dasar (Riskesdas) 2013. Jakarta: Kementerian Kesehatan Republik Indonesia; 2013.

Roozendaal BW, Krass I. Development of an evidence-based checklist for the detection of drug related problems in Type 2 diabetes. Pharm World Sci 2009;31(5):580-95.

Wiener ES, Mullins CD, Pincus KJ. A framework for pharmacist-assisted medication adherence in hard-to-reach patients. Res Soc Adm Pharm 2015;11(5):595-601.

Khan H, Lasker SS, Chowdhury TA. Exploring reasons for very poorglycaemic control in patients with Type 2 diabetes. Prim Care Diabetes 2011;5(4):251-5.

Asmini P. the influence of education of drug information by pharmacist on the improvement of knowledge and therapeutic target to Type 2 diabetes mellitus outpatients in hospital. Int J Pharm Pharm Sci 2017;9(3):199.

Tanenbaum ML, Kane NS, Kenowitz J, Gonzalez JS. Diabetes distress from the patientâ€™s perspective: Qualitative themes and treatment regimen differences among adults with Type 2 diabetes. J Diabetes Complications 2016;30(6):1060-8.

Indelicato L, Dauriz M, Santi L, Bonora F, Negri C, Cacciatori V, et al. Psychological distress, self-efficacy and glycemic control in Type 2 diabetes. Nutr Metab Cardiovasc Dis 2017;27(4):300-6.

Sapkota NK. Glycemic control in smokers and risk of Type 2 diabetes. Innov J Health Sci 2016;4(5):1-2.

Appalasamy J, Sarriff A. A survey of drug-related problems among patients treated for allergy symptoms in community pharmacies at Negeri Sembilan, Malaysia. Int J Pharm Pharm Sci 2014;6(10):313-6.